[The present status of treatment of unstable angina pectoris].

UAP is a frequent manifestation of ischaemic heart disease; it is intermediary between stable angina and myocardial infarction and sudden death resp. The hospitalization mortality is 5%, approximately 15% of the patients with UAP develop myocardial infarction. The aim of UAP treatment is: 1.

[Hypercoagulation states].

Hypercoagulability is a condition where as a result of certain pathological changes in the blood inadequate cumulation of thrombocytes or fibrin occurs which finally can lead to arterial or venous thrombosis, depending on vascular wall damage. In the submitted review the authors analyze the most important inborn and acquired causes of hypercoagulation states. As to inborn causes, deficiens of natural anticoagulation proteins (antithrombin III, protein C, protein S) are most important as well as dysfibrinogenaemia, impaired fibrinolysis associated with deficiency of natural activators of fibrinolysis or increased activity of their inhibitors and homocystinuria.

Risk factors for atherosclerosis in female type II diabetic patients with incipient diabetic nephropathy.

Risk factors for atherosclerosis were investigated in a group of 17 female Type II diabetic patients with microalbuminuria-urinary albumin excretion (UAE) in the range of 30-300 mg/day, and in a control group including 15 Type II diabetic females with UAE less than 30 mg/day. Significantly increased mean concentrations of total and LDL-cholesterol were measured in the group with microalbuminuria (p less than 0.05).